[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"infection-due-to-carbapenem-resistant-acinetobacter\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:infection-due-to-carbapenem-resistant-acinetobacter":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100559954","phase-4-colistin-monotherapy-vs-colsitin-fosfomycine-in-crab-infection-100559954",false,"NCT06570850","Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection","Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections","Inclusion Criteria:\n\n* ≥ 20 years old patients who have CRAB infections (pneumonia, urinary tract infection, skin and soft tissue infection, bloodstream infection)\n* Able to provide informed consent or having a legal proxy who can provide informed consent in case the subject is unable to provide consent on his own\n\nExclusion Criteria:\n\n* Minimum inhibitory concentration (MIC) of colistin \\> 2 mg\u002FL\n* Complicated infection with inadequate source controlled\n* Intracranial infection\n* Infective endocarditis\n* Intraabdominal infection\n* Bone and joint infection\n* Allergic to or have contraindication(s) to any treatment regimen in the study\n* Polymicrobial infection with Carbapenem-resistant Psuedomonas aeruginosa, Carbapenem-resistant Enterobacterales (CRE), Vancomycin-resistant Enterococcus (VRE)\n* Pregnancy\n* Previous treatment with colistin or fosfomycin more than 96 hours\n* Life expectancy of 24 hour or less\n* Refusal to participate in the study\n* Hospice treatment","ALL","20 Years",{"count":19,"type":20},188,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions:\n\n1. Which group has better clinical response at end of treatment\n2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment",[26],"Infection Due to Carbapenem Resistant Acinetobacter",[28,29,30,31],"carbapenem resistant Acinetobacter baumanni","CRAB","Colistin","Fosfomycin","RECRUITING","2024-08-22",{"date":35,"type":36},"2024-08-26","ACTUAL",{"date":38,"type":36},"2023-04-01",{"date":40,"type":20},"2025-07",{"name":42,"class":43},"Chiang Mai University","OTHER"]